EAM
ADVM

Eventide Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Eventide Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-72,000
Closed -$8.56M – 125
2019
Q2 		$8.56M Sell
72,000
-42,658
-37% -$3.53M 0.26% 80
2019
Q1 		$6.01M Hold
114,658
– – 0.21% 87
2018
Q4 		$3.61M Buy
+114,658
New +$4.66M 0.16% 94
2015
Q2 		– Sell
-3,740
Closed -$1.51M – 111
2015
Q1 		$1.51M Buy
3,740
+500
+15% +$211K 0.11% 101
2014
Q4 		$1.75M Buy
3,240
+1,240
+62% +$478K 0.19% 81
2014
Q3 		$684K Buy
+2,000
New +$595K 0.1% 97

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GTC
Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return